<p>An adequate blood plasma level of 17-beta-estradiol or ethinyl estradiol is attained in a patient in need of estrogen therapy by administration of a dose of 17-beta-estradiol or ethinyl estradiol or a pharmaceutically acceptable ester thereof not greater than 150 micrograms into the vestibule of the buccal cavity of the patient and maintaining the dose in contact with the oral mucosa for a period of time sufficient for transmucosal absorption of a sufficient amount of estrogen to produce a therapeutically effective plasma concentration of estrogen.</p>
申请公布号
DE3873391(T2)
申请公布日期
1992.12.03
申请号
DE19883873391T
申请日期
1988.04.08
申请人
ZETACHRON, INC., STATE COLLEGE, PA., US
发明人
KEITH, ALEC D., BOALSBURG PENNSYLVANIA 16801, US;SNIPES, WALLACE C., PINE GROVE MILLS PENNSYLVANIA 16868, US